Cargando…

Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases

BACKGROUND: Giant cell tumor of the tendon sheath is the most common form of giant cell tumors and is the second most common soft tissue tumor of the hand region after ganglion cyst. Magnetic resonance imaging is the diagnostic tool of choice for both diagnosis and treatment planning. The current st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozben, Hakan, Coskun, Tamer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805347/
https://www.ncbi.nlm.nih.gov/pubmed/31638958
http://dx.doi.org/10.1186/s12891-019-2866-8
_version_ 1783461361632673792
author Ozben, Hakan
Coskun, Tamer
author_facet Ozben, Hakan
Coskun, Tamer
author_sort Ozben, Hakan
collection PubMed
description BACKGROUND: Giant cell tumor of the tendon sheath is the most common form of giant cell tumors and is the second most common soft tissue tumor of the hand region after ganglion cyst. Magnetic resonance imaging is the diagnostic tool of choice for both diagnosis and treatment planning. The current standard treatment of choice is simple excision. The main concern about the treatment is related to the high recurrence rates. Besides incomplete excision, there is no consensus concerning the effect of other risk factors on recurrence. The literature lacks detailed reports on surgical excision of these tumors with a standardized surgical treatment and an appropriate patient follow up. The aim of this study was to investigate the recurrence rate and the associated recurrence risk factors for giant cell tumor of tendon sheath of the hand following a standardized treatment. METHODS: The records of patients treated for giant cell tumor of tendon sheath of the hand treated by the same hand surgeon were evaluated retrospectively. The features obtained from preoperative magnetic resonance imaging, final physical examination, patients’ age and sex, anatomical site of the tumor, relationship of the tumor with bone, joint or neurovascular structures, bone invasion, recurrence after surgery and complications like skin necrosis, digital neuropathy or limitation in range of motion were documented. Chi-square test was used to compare categorical variables. RESULTS: Fifty patient were included in the study. The average follow-up time was 84 months. Three recurrences (6%) were recorded. The only significant risk factor for the recurrence was tumor adjacency to the interphalangeal joints of the fingers other than thumb. No major or minor complications were encountered in the postoperative period. CONCLUSION: With adequate surgical exposure and meticulous dissection provided by the magnification loupes, we were able demonstrate one of the lowest recurrence rates in the literature. Well-designed studies combining the recurrence rates of several hand surgery centers implementing a standardized treatment are needed to better demonstrate the associated risk factors for recurrence.
format Online
Article
Text
id pubmed-6805347
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68053472019-10-24 Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases Ozben, Hakan Coskun, Tamer BMC Musculoskelet Disord Research Article BACKGROUND: Giant cell tumor of the tendon sheath is the most common form of giant cell tumors and is the second most common soft tissue tumor of the hand region after ganglion cyst. Magnetic resonance imaging is the diagnostic tool of choice for both diagnosis and treatment planning. The current standard treatment of choice is simple excision. The main concern about the treatment is related to the high recurrence rates. Besides incomplete excision, there is no consensus concerning the effect of other risk factors on recurrence. The literature lacks detailed reports on surgical excision of these tumors with a standardized surgical treatment and an appropriate patient follow up. The aim of this study was to investigate the recurrence rate and the associated recurrence risk factors for giant cell tumor of tendon sheath of the hand following a standardized treatment. METHODS: The records of patients treated for giant cell tumor of tendon sheath of the hand treated by the same hand surgeon were evaluated retrospectively. The features obtained from preoperative magnetic resonance imaging, final physical examination, patients’ age and sex, anatomical site of the tumor, relationship of the tumor with bone, joint or neurovascular structures, bone invasion, recurrence after surgery and complications like skin necrosis, digital neuropathy or limitation in range of motion were documented. Chi-square test was used to compare categorical variables. RESULTS: Fifty patient were included in the study. The average follow-up time was 84 months. Three recurrences (6%) were recorded. The only significant risk factor for the recurrence was tumor adjacency to the interphalangeal joints of the fingers other than thumb. No major or minor complications were encountered in the postoperative period. CONCLUSION: With adequate surgical exposure and meticulous dissection provided by the magnification loupes, we were able demonstrate one of the lowest recurrence rates in the literature. Well-designed studies combining the recurrence rates of several hand surgery centers implementing a standardized treatment are needed to better demonstrate the associated risk factors for recurrence. BioMed Central 2019-10-21 /pmc/articles/PMC6805347/ /pubmed/31638958 http://dx.doi.org/10.1186/s12891-019-2866-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ozben, Hakan
Coskun, Tamer
Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
title Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
title_full Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
title_fullStr Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
title_full_unstemmed Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
title_short Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
title_sort giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805347/
https://www.ncbi.nlm.nih.gov/pubmed/31638958
http://dx.doi.org/10.1186/s12891-019-2866-8
work_keys_str_mv AT ozbenhakan giantcelltumoroftendonsheathinthehandanalysisofriskfactorsforrecurrencein50cases
AT coskuntamer giantcelltumoroftendonsheathinthehandanalysisofriskfactorsforrecurrencein50cases